 |
|
 |
| Market Info |
 |
|
EXPAND TICKER |
 |
|
|
|
|
 |
 |
|
| You are here : Corporate Information | Financial Ratios |
|
|
 |
|
|
|
|
|
|
|
Your Result on : Corporate Information | Financial Ratios |
|
|
|
| Aptus Pharma Ltd |
Industry: Pharmaceuticals - Indian - Formulations |
|
|
| BSE Code |
ISIN Demat |
Book Value
(R) |
NSE
Symbol |
Div Yield
% |
Market Cap
(Rs.Cr) |
P/E
(TTM) |
EPS
(TTM) |
Face Value
(R) |
| 544529 |
INE15XJ01010 |
29.1342566 |
N.A |
0 |
88.27 |
0 |
0 |
10 |
|
|
| Particulars | Mar 2025 | Mar 2024 | | Debt-Equity Ratio | 1.79 | 2.74 | | Long Term Debt-Equity Ratio | 0.75 | 2.18 | | Current Ratio | 1.74 | 1.94 | | Fixed Assets | 15.85 | 16.61 | | Inventory | 4.68 | 6.23 | | Debtors | 5.46 | 6.21 | | Interest Cover Ratio | 9.94 | 5.67 | | PBIDTM (%) | 20.07 | 8.79 | | PBITM (%) | 18.97 | 7.61 | | PBDTM (%) | 18.16 | 7.45 | | CPM (%) | 13.72 | 5.66 | | APATM (%) | 12.62 | 4.48 | | ROCE (%) | 37.63 | 25.83 | | RONW (%) | 70.94 | 58.39 |
|
|
|
|
|
|
|
|
|
|
|
 |
|